Lalla, Jackson
Gibson, Victoria
Messier, Terri
Cunniff, Brian
Funding for this research was provided by:
RS Oncology
Article History
Received: 19 May 2025
Accepted: 18 September 2025
First Online: 30 September 2025
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: BC is funded by RS Oncology, LLC through a Sponsored Research Contract to the University of Vermont. RS Oncology is developing therapies for mesothelioma. V.G was supported in part by the University of Vermont Cancer Center, the Vermont Lung Center, and the Butler Family Foundation. T.M., and B.C. are paid consultants and B.C. is an equity holders in RS Oncology, LLC.